Aglaia Klinikken ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  7.5% 7.5% 7.5% 7.5% 7.5%  
Bankruptcy risk  2.6% 1.9% 2.1% 2.3% 2.1%  
Credit score (0-100)  62 70 66 64 66  
Credit rating  BBB A A BBB A  
Credit limit (kDKK)  0.0 1.3 0.3 0.0 0.4  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  1,896 2,774 3,008 2,946 2,650  
EBITDA  1,255 1,974 2,190 1,904 1,676  
EBIT  1,167 1,873 2,022 1,779 1,588  
Pre-tax profit (PTP)  1,159.3 1,860.0 2,001.1 1,736.2 1,611.2  
Net earnings  903.0 1,435.4 1,557.3 1,348.4 1,254.6  
Pre-tax profit without non-rec. items  1,159 1,860 2,001 1,736 1,611  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  229 528 360 235 147  
Shareholders equity total  893 2,273 2,330 1,678 2,874  
Interest-bearing liabilities  93.4 142 149 155 159  
Balance sheet total (assets)  1,589 3,754 3,439 2,635 3,968  

Net Debt  -862 -2,339 -2,536 -1,910 -3,283  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,896 2,774 3,008 2,946 2,650  
Gross profit growth  -13.5% 46.3% 8.4% -2.1% -10.0%  
Employees  1 1 1 2 1  
Employee growth %  0.0% 0.0% 0.0% 100.0% -50.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,589 3,754 3,439 2,635 3,968  
Balance sheet change%  -29.4% 136.3% -8.4% -23.4% 50.6%  
Added value  1,254.9 1,973.7 2,189.9 1,946.0 1,675.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -175 198 -335 -252 -176  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  61.6% 67.5% 67.2% 60.4% 59.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  60.8% 70.1% 56.2% 58.6% 49.0%  
ROI %  88.3% 109.3% 82.2% 82.3% 66.5%  
ROE %  74.1% 90.7% 67.7% 67.3% 55.1%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  56.2% 60.5% 67.8% 63.7% 72.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -68.7% -118.5% -115.8% -100.3% -195.9%  
Gearing %  10.5% 6.2% 6.4% 9.2% 5.5%  
Net interest  0 0 0 0 0  
Financing costs %  8.8% 11.0% 14.7% 27.8% 5.1%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.4 1.7 2.4 2.2 3.2  
Current Ratio  1.9 2.0 2.8 2.5 3.5  
Cash and cash equivalent  954.9 2,480.4 2,685.2 2,065.3 3,442.3  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  635.9 1,520.3 1,940.6 1,407.9 2,691.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  1,255 1,974 2,190 973 1,676  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  1,255 1,974 2,190 952 1,676  
EBIT / employee  1,167 1,873 2,022 889 1,588  
Net earnings / employee  903 1,435 1,557 674 1,255